<!DOCTYPE html>
<html lang="en">

<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Thyroid Nodules and Thyroid Cancer: An Overview</title>
 <style>
 /* Base & Reset */
 * {
 box-sizing: border-box;
 }

 body {
 font-family: Georgia, 'Times New Roman', serif;
 line-height: 1.8;
 color: #2d2d2d;
 background: #f8f6f3;
 margin: 0;
 padding: 0;
 }

 /* Main Container */
 .lesson-container {
 max-width: 860px;
 margin: 0 auto;
 padding: 40px 30px;
 background: #ffffff;
 min-height: 100vh;
 box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
 }

 /* Module Header */
 .module-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 35px 35px 30px;
 border-radius: 16px;
 margin-bottom: 30px;
 position: relative;
 overflow: hidden;
 }

 .module-header::before {
 content: '';
 position: absolute;
 top: 0;
 right: 0;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
 transform: translate(100px, -100px);
 }

 .module-header::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 100%;
 height: 4px;
 background: #B8860B;
 }

 .module-label {
 margin: 0;
 font-size: 11px;
 color: rgba(255, 255, 255, 0.75);
 text-transform: uppercase;
 letter-spacing: 2.5px;
 font-weight: 500;
 }

 .lesson-title {
 margin: 10px 0 0 0;
 font-size: 28px;
 color: #ffffff;
 font-weight: 700;
 line-height: 1.3;
 position: relative;
 }

 .lesson-meta {
 display: flex;
 gap: 12px;
 margin-top: 20px;
 padding-top: 18px;
 border-top: 1px solid rgba(255, 255, 255, 0.15);
 flex-wrap: wrap;
 }

 .meta-item {
 display: flex;
 align-items: center;
 gap: 6px;
 font-size: 12px;
 color: rgba(255, 255, 255, 0.85);
 background: rgba(255, 255, 255, 0.1);
 padding: 5px 12px;
 border-radius: 4px;
 }

 /* Table of Contents */
 .toc-box {
 background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
 border-radius: 14px;
 padding: 24px 28px;
 margin-bottom: 35px;
 border: 1px solid #e8e8e8;
 }

 .toc-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 padding-bottom: 12px;
 border-bottom: 1px solid #e0e0e0;
 }

 .toc-list {
 list-style: none;
 margin: 0;
 padding: 0;
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 8px 24px;
 }

 .toc-list li {
 margin: 0;
 }

 .toc-list a {
 display: flex;
 align-items: center;
 padding: 8px 12px;
 color: #555;
 text-decoration: none;
 font-size: 14px;
 border-radius: 6px;
 transition: all 0.2s ease;
 }

 .toc-list a:hover {
 background: white;
 color: #047857;
 box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
 }

 .toc-list .section-num {
 display: inline-flex;
 align-items: center;
 justify-content: center;
 width: 26px;
 height: 26px;
 background: #047857;
 color: white;
 font-weight: 600;
 font-size: 11px;
 border-radius: 6px;
 margin-right: 12px;
 flex-shrink: 0;
 }

 @media (max-width: 600px) {
 .toc-list {
 grid-template-columns: 1fr;
 }
 }

 /* Learning Objectives */
 .objectives-box {
 background: #ecfdf5;
 border: 2px solid #047857;
 border-radius: 14px;
 padding: 30px 35px;
 margin-bottom: 40px;
 }

 .objectives-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 display: flex;
 align-items: center;
 gap: 10px;
 }

 .objectives-box .box-label::before {
 content: 'ðŸŽ¯';
 font-size: 18px;
 }

 .objectives-box ul {
 margin: 0;
 padding-left: 22px;
 }

 .objectives-box li {
 margin-bottom: 14px;
 font-size: 16px;
 line-height: 1.7;
 }

 .objectives-box li:last-child {
 margin-bottom: 0;
 }

 /* Key Terms Box */
 .key-terms-box {
 background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
 border-radius: 14px;
 padding: 28px 30px;
 margin: 40px 0;
 border: 1px solid #d8dce0;
 }

 .key-terms-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .terms-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 }

 .term-item {
 background: white;
 padding: 16px 18px;
 border-radius: 10px;
 border-left: 4px solid #059669;
 }

 .term-item .term {
 font-weight: 700;
 color: #059669;
 font-size: 15px;
 margin: 0 0 6px 0;
 }

 .term-item .definition {
 font-size: 14px;
 color: #555;
 margin: 0;
 line-height: 1.6;
 }

 /* Section Headings */
 h2 {
 font-size: 24px;
 color: #047857;
 margin: 50px 0 20px 0;
 font-weight: 600;
 position: relative;
 padding-bottom: 12px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 3px;
 background: #B8860B;
 }

 /* Paragraphs */
 p {
 font-size: 17px;
 margin-bottom: 20px;
 color: #333;
 }

 /* Highlights */
 .highlight {
 background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
 padding: 0 4px;
 font-weight: 500;
 color: inherit; /* Ensures text color inherits from parent */
 }

 /* Welcome/Intro Box */
 .welcome-box {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 padding: 30px 35px;
 border-radius: 14px;
 margin-bottom: 40px;
 border: 1px solid #bbf7d0;
 }

 .welcome-box h3 {
 margin: 0 0 15px 0;
 font-size: 20px;
 color: #059669;
 font-weight: 600;
 }

 .welcome-box p {
 margin: 0;
 font-size: 17px;
 line-height: 1.8;
 color: #444;
 }

 /* Alert Boxes */
 .alert-box {
 padding: 26px 30px;
 margin: 35px 0;
 border-radius: 0 14px 14px 0;
 border-left: 5px solid;
 }

 .alert-box .alert-label {
 font-weight: 600;
 margin: 0 0 12px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .alert-box p:last-child {
 margin: 0;
 font-size: 16px;
 line-height: 1.7;
 }

 .alert-box.warning {
 background: #fff8e6;
 border-left-color: #ff9800;
 }

 .alert-box.warning .alert-label {
 color: #e65100;
 }

 .alert-box.success {
 background: #f0f8f0;
 border-left-color: #4caf50;
 }

 .alert-box.success .alert-label {
 color: #2e7d32;
 }

 .alert-box.reflect {
 background: #f8f0fa;
 border-left-color: #9c27b0;
 }

 .alert-box.reflect .alert-label {
 color: #7b1fa2;
 }

 .alert-box.info {
 background: #e3f2fd;
 border-left-color: #2196f3;
 }

 .alert-box.info .alert-label {
 color: #1565c0;
 }

 /* Case Study Box */
 .case-study {
 background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
 border-radius: 16px;
 padding: 0;
 margin: 40px 0;
 overflow: hidden;
 box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
 border-left: 5px solid #047857;
 }

 .case-study-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 20px 30px;
 display: flex;
 align-items: center;
 gap: 15px;
 }

 .case-study-icon {
 width: 45px;
 height: 45px;
 background: rgba(255, 255, 255, 0.15);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 }

 .case-study-header .box-label {
 font-weight: 600;
 color: #ffffff;
 margin: 0;
 font-size: 16px;
 letter-spacing: 0.5px;
 }

 .case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 13px;
 margin: 4px 0 0 0;
 }

 .case-study-content {
 padding: 28px 30px;
 }

 .case-study-content p {
 font-size: 16px;
 margin-bottom: 18px;
 }

 .case-study-content ul {
 margin: 18px 0;
 padding-left: 22px;
 }

 .case-study-content li {
 margin-bottom: 10px;
 font-size: 15px;
 }

 .patient-profile {
 display: flex;
 align-items: center;
 gap: 18px;
 padding: 18px 22px;
 background: white;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e5e5;
 }

 .patient-avatar {
 width: 55px;
 height: 55px;
 background: linear-gradient(135deg, #10B981, #059669);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 flex-shrink: 0;
 }

 .patient-info h4 {
 margin: 0 0 5px 0;
 font-size: 17px;
 color: #1a1a1a;
 }

 .patient-info p {
 margin: 0;
 font-size: 14px;
 color: #666;
 }

 /* Comparison Cards */
 .comparison-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 20px;
 margin: 30px 0;
 }

 .comparison-card {
 border-radius: 14px;
 padding: 26px;
 border-top: 5px solid;
 transition: transform 0.2s ease;
 }

 .comparison-card:hover {
 transform: translateY(-3px);
 }

 .comparison-card.conventional {
 background: #fff5f5;
 border-top-color: #c62828;
 }

 .comparison-card.functional {
 background: #f1f8f1;
 border-top-color: #2e7d32;
 }

 .comparison-card .card-label {
 font-weight: 600;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 margin: 0 0 14px 0;
 }

 .comparison-card.conventional .card-label {
 color: #c62828;
 }

 .comparison-card.functional .card-label {
 color: #2e7d32;
 }

 .comparison-card .card-text {
 margin: 0;
 font-size: 16px;
 font-style: italic;
 line-height: 1.6;
 }

 /* Content Lists */
 .content-list {
 font-size: 17px;
 margin: 20px 0;
 padding-left: 24px;
 }

 .content-list li {
 margin-bottom: 14px;
 line-height: 1.7;
 }

 .content-list li:last-child {
 margin-bottom: 0;
 }

 /* Statistics Box */
 .stats-box {
 background: linear-gradient(135deg, #059669 0%, #10B981 100%);
 padding: 40px;
 border-radius: 16px;
 margin: 35px 0;
 position: relative;
 overflow: hidden;
 }

 .stats-box::before {
 content: '';
 position: absolute;
 top: -50%;
 right: -20%;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.08) 0%, transparent 70%);
 }

 .stats-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
 gap: 25px;
 position: relative;
 }

 .stat-item {
 text-align: center;
 }

 .stat-number {
 font-size: 42px;
 font-weight: 700;
 color: white;
 line-height: 1;
 margin-bottom: 8px;
 }

 .stat-label {
 font-size: 13px;
 color: rgba(255, 255, 255, 0.85);
 text-transform: uppercase;
 letter-spacing: 1px;
 }

 /* Principle Cards */
 .principle-card {
 background: linear-gradient(to right, #fafafa, #ffffff);
 border-left: 5px solid #059669;
 padding: 24px 28px;
 margin-bottom: 18px;
 border-radius: 0 14px 14px 0;
 box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
 transition: transform 0.2s ease, box-shadow 0.2s ease;
 }

 .principle-card:hover {
 transform: translateX(5px);
 box-shadow: 0 4px 18px rgba(0, 0, 0, 0.08);
 }

 .principle-card .principle-title {
 font-weight: 700;
 color: #059669;
 margin: 0 0 10px 0;
 font-size: 17px;
 }

 .principle-card .principle-text {
 margin: 0;
 font-size: 15px;
 line-height: 1.7;
 }

 .principle-card ul {
 margin: 12px 0 0 0;
 padding-left: 20px;
 font-size: 14px;
 }

 .principle-card li {
 margin-bottom: 5px;
 }

 /* Check Understanding Box */
 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }
 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }
 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }
 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }
 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }

 /* Key Takeaways */
 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }
 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }
 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }
 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 /* Interactive Diagram */
 .interactive-diagram {
 background: white;
 border: 2px solid #e5e5e5;
 border-radius: 16px;
 padding: 30px;
 margin: 35px 0;
 text-align: center;
 }

 .diagram-title {
 font-weight: 600;
 color: #333;
 margin: 0 0 20px 0;
 font-size: 18px;
 }

 .gut-visual {
 display: flex;
 justify-content: center;
 align-items: center;
 gap: 30px;
 flex-wrap: wrap;
 margin: 20px 0;
 }

 .gut-section {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 border: 2px solid #10B981;
 border-radius: 12px;
 padding: 20px;
 min-width: 150px;
 cursor: pointer;
 transition: all 0.3s ease;
 }

 .gut-section:hover {
 transform: scale(1.05);
 box-shadow: 0 8px 25px rgba(16, 185, 129, 0.2);
 }

 .gut-section .icon {
 font-size: 32px;
 margin-bottom: 10px;
 }

 .gut-section .label {
 font-weight: 600;
 color: #059669;
 font-size: 14px;
 }

 .gut-section .count {
 font-size: 12px;
 color: #666;
 margin-top: 5px;
 }

 /* Footer */
 .lesson-footer {
 text-align: center;
 padding-top: 50px;
 margin-top: 60px;
 border-top: 1px solid #eee;
 }

 .footer-logo {
 max-width: 140px;
 height: auto;
 margin-bottom: 15px;
 opacity: 0.9;
 }

 .lesson-footer .brand {
 color: #059669;
 font-weight: 600;
 margin: 0;
 font-size: 15px;
 }

 .lesson-footer .copyright {
 color: #888;
 font-size: 13px;
 margin: 10px 0 0 0;
 }

 /* Responsive */
 @media (max-width: 768px) {
 .lesson-container {
 padding: 20px 16px;
 }

 .module-header {
 padding: 25px 20px 22px;
 }

 .lesson-title {
 font-size: 22px;
 }

 h2 {
 font-size: 20px;
 margin: 35px 0 15px 0;
 }

 p {
 font-size: 16px;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .objectives-box {
 padding: 25px 20px;
 }

 .key-terms-box {
 padding: 22px 18px;
 }

 .terms-grid {
 grid-template-columns: 1fr;
 }

 .stats-box {
 padding: 25px 20px;
 }

 .stat-number {
 font-size: 32px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .principle-card {
 padding: 20px;
 }

 .case-study-content {
 padding: 20px;
 }

 .check-understanding {
 padding: 25px 20px;
 }

 .takeaways-box {
 padding: 18px 20px;
 }

 .alert-box {
 padding: 20px;
 }

 .content-list {
 padding-left: 20px;
 font-size: 16px;
 }
 }

 @media (max-width: 480px) {
 .lesson-container {
 padding: 15px 12px;
 }

 .brand-logo {
 max-width: 180px;
 }

 .stats-grid {
 grid-template-columns: repeat(2, 1fr);
 gap: 15px;
 }
 }

 .data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
 .data-table th { background: #059669; color: white; padding: 12px 15px; text-align: left; }
 .data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
 .data-table tr:nth-child(even) { background: #f9fafb; }
 </style>
</head>

<body>
 <div class="lesson-container">
 <header class="module-header">
 <p class="module-label">Module 6: L1 Deep Dive Module 6</p>
 <h1 class="lesson-title">Lesson 6: Thyroid Nodules and Thyroid Cancer: An Overview</h1>
 <div class="lesson-meta">
 <span class="meta-item">14 min read</span>
 <span class="meta-item">Lesson 6 of 8</span>
 </div>
 </header>

 <!-- Table of Contents -->
 <div class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#section1"><span class="section-num">1</span>Understanding Thyroid Nodules</a></li>
 <li><a href="#section2"><span class="section-num">2</span>Thyroid Ultrasound: A Closer Look</a></li>
 <li><a href="#section3"><span class="section-num">3</span>Fine-Needle Aspiration (FNA) Biopsy</a></li>
 <li><a href="#section4"><span class="section-num">4</span>Types of Thyroid Cancer</a></li>
 <li><a href="#section5"><span class="section-num">5</span>Post-Thyroidectomy Management</a></li>
 <li><a href="#section6"><span class="section-num">6</span>Iodine and Thyroid Cancer</a></li>
 </ul>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Identify the prevalence and characteristics of thyroid nodules, differentiating between benign and malignant cases.</li>
 <li>Interpret thyroid ultrasound findings, including size, echogenicity, margins, and calcifications, using the Bethesda System.</li>
 <li>Describe the indications, technique, and interpretation of fine-needle aspiration (FNA) biopsy results, and the role of molecular testing.</li>
 <li>Distinguish between the different types of thyroid cancer (papillary, follicular, medullary, and anaplastic) and their respective prognoses and treatment options.</li>
 <li>Outline post-thyroidectomy management strategies, including thyroid hormone replacement and recurrence monitoring.</li>
 <li>Explain the role of a low-iodine diet in preparation for radioactive iodine therapy in thyroid cancer patients.</li>
 </ul>
 </div>

 <!-- Introduction -->
 <div class="welcome-box">
 <h3>Navigating Thyroid Nodules and Cancer</h3>
 <p>Welcome to a crucial lesson in our Certified Thyroid Health Specialistâ„¢ program. Building upon our previous discussions on thyroid physiology, lab interpretation, and autoimmune thyroid diseases, we now delve into the complexities of <span class="highlight">thyroid nodules</span> and <span class="highlight">thyroid cancer</span>. This lesson is designed to equip you with the knowledge and skills to confidently assess, manage, and support clients facing these challenging conditions, always keeping in mind the holistic perspective of The G.L.A.N.D. Frameworkâ„¢.</p>
 </div>

 <h2 id="section1">Understanding Thyroid Nodules</h2>
 <p>Thyroid nodules are common, with a prevalence of <span class="stat-highlight">4-7%</span> by palpation and <span class="stat-highlight">20-76%</span> by ultrasound in the adult population (Gharib et al., 2013). Most are benign, but a small percentage harbor malignancy. Risk factors include age, sex (more common in women), iodine deficiency, radiation exposure, and family history of thyroid cancer. Diagnostic workup typically involves thyroid ultrasound and, if indicated, fine-needle aspiration (FNA) biopsy.</p>

 <h2 id="section2">Thyroid Ultrasound: A Closer Look</h2>
 <p>Thyroid ultrasound is a non-invasive imaging technique that provides valuable information about nodule size, echogenicity (how dark or light the nodule appears), margins (smooth or irregular), and the presence of calcifications. The <span class="highlight">Bethesda System for Reporting Thyroid Cytopathology</span> isa standardized classification system used to report FNA results and guide clinical management (Cibas & Ali, 2017). Ultrasound features suggestive of malignancy include hypoechogenicity, irregular margins, microcalcifications, taller-than-wide shape, and absence of a halo.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Ultrasound Feature</th>
 <th>Description</th>
 <th>Malignancy Risk</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Echogenicity</td>
 <td>Hypoechoic (darker than surrounding tissue)</td>
 <td>Increased</td>
 </tr>
 <tr>
 <td>Margins</td>
 <td>Irregular or poorly defined</td>
 <td>Increased</td>
 </tr>
 <tr>
 <td>Calcifications</td>
 <td>Microcalcifications (tiny, punctate)</td>
 <td>Increased</td>
 </tr>
 <tr>
 <td>Shape</td>
 <td>Taller-than-wide (on transverse view)</td>
 <td>Increased</td>
 </tr>
 <tr>
 <td>Halo</td>
 <td>Absence of a hypoechoic halo around the nodule</td>
 <td>Increased</td>
 </tr>
 <tr>
 <td>Size</td>
 <td>Nodules >1 cm generally warrant further evaluation</td>
 <td>Variable, but size thresholds influence workup decisions</td>
 </tr>
 </tbody>
 </table>

 <h2 id="section3">Fine-Needle Aspiration (FNA) Biopsy</h2>
 <p>FNA biopsy is the gold standard for evaluating thyroid nodules suspected of malignancy based on ultrasound findings. The procedure involves inserting a thin needle into the nodule to collect cells for cytological examination. FNA is typically performed under ultrasound guidance to ensure accurate sampling. The Bethesda System categorizes FNA results into six diagnostic categories, each with an associated risk of malignancy and recommended management strategy.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Bethesda Category</th>
 <th>Description</th>
 <th>Risk of Malignancy</th>
 <th>Recommended Management</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>I. Non-diagnostic</td>
 <td>Insufficient or inadequate sample</td>
 <td>5-10%</td>
 <td>Repeat FNA or consider alternative diagnostic approach</td>
 </tr>
 <tr>
 <td>II. Benign</td>
 <td>Consistent with a benign follicular nodule, adenomatoid nodule, etc.</td>
 <td>0-3%</td>
 <td>Clinical follow-up, repeat ultrasound in 6-12 months</td>
 </tr>
 <tr>
 <td>III. Atypia of Undetermined Significance (AUS) or Follicular Lesion of Undetermined Significance (FLUS)</td>
 <td>Cells with atypical features that are not clearly benign or malignant</td>
 <td>5-15%</td>
 <td>Repeat FNA, molecular testing, or surgical excision</td>
 </tr>
 <tr>
 <td>IV. Follicular Neoplasm or Suspicious for a Follicular Neoplasm</td>
 <td>Cells with features suggestive of a follicular neoplasm (adenoma or carcinoma)</td>
 <td>15-30%</td>
 <td>Surgical excision (lobectomy) for diagnosis and treatment</td>
 </tr>
 <tr>
 <td>V. Suspicious for Malignancy</td>
 <td>Cells with features highly suggestive of malignancy but not definitive</td>
 <td>60-75%</td>
 <td>Near-total or total thyroidectomy</td>
 </tr>
 <tr>
 <td>VI. Malignant</td>
 <td>Cells with definitive features of malignancy (papillary thyroid carcinoma, medullary thyroid carcinoma, etc.)</td>
 <td>97-99%</td>
 <td>Near-total or total thyroidectomy, radioactive iodine therapy (if indicated)</td>
 </tr>
 </tbody>
 </table>

 <p>In cases with indeterminate FNA results (Bethesda categories III and IV), molecular testing can be performed on the FNA sample to further refine the risk of malignancy. These tests analyze gene mutations and expression patterns associated with thyroid cancer, helping to guide surgical decision-making (Nikiforov et al., 2011).</p>

 <h2 id="section4">Types of Thyroid Cancer</h2>
 <p>Thyroid cancer is classified into four main types: papillary, follicular, medullary, and anaplastic. <span class="highlight">Papillary thyroid carcinoma (PTC)</span> is the most common type, accounting for <span class="stat-highlight">80-85%</span> of all thyroid cancers. It is typically slow-growing and has an excellent prognosis, with a <span class="stat-highlight">10-year survival rate of over 95%</span> (Haugen et al., 2016). <span class="highlight">Follicular thyroid carcinoma (FTC)</span> accounts for <span class="stat-highlight">10-15%</span> of cases and also has a good prognosis. <span class="highlight">Medullary thyroid carcinoma (MTC)</span> arises from the parafollicular C cells of the thyroid and accounts for <span class="stat-highlight">3-5%</span> of cases. It is associated with multiple endocrine neoplasia (MEN) syndromes. <span class="highlight">Anaplastic thyroid carcinoma (ATC)</span> is a rare but aggressive type of thyroid cancer with a poor prognosis.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Type of Thyroid Cancer</th>
 <th>Origin</th>
 <th>Prevalence</th>
 <th>Prognosis</th>
 <th>Treatment</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Papillary Thyroid Carcinoma (PTC)</td>
 <td>Follicular cells</td>
 <td>80-85%</td>
 <td>Excellent</td>
 <td>Surgery, radioactive iodine therapy (if indicated)</td>
 </tr>
 <tr>
 <td>Follicular Thyroid Carcinoma (FTC)</td>
 <td>Follicular cells</td>
 <td>10-15%</td>
 <td>Good</td>
 <td>Surgery, radioactive iodine therapy (if indicated)</td>
 </tr>
 <tr>
 <td>Medullary Thyroid Carcinoma (MTC)</td>
 <td>Parafollicular C cells</td>
 <td>3-5%</td>
 <td>Variable, depends on stage and genetics</td>
 <td>Surgery, tyrosine kinase inhibitors (for advanced disease)</td>
 </tr>
 <tr>
 <td>Anaplastic Thyroid Carcinoma (ATC)</td>
 <td>Follicular cells (dedifferentiated)</td>
 <td>1-2%</td>
 <td>Poor</td>
 <td>Surgery, radiation therapy, chemotherapy</td>
 </tr>
 </tbody>
 </table>

 <h2 id="section5">Post-Thyroidectomy Management</h2>
 <p>Following thyroidectomy (surgical removal of the thyroid gland), patients require lifelong thyroid hormone replacement therapy to maintain normal thyroid hormone levels. The goal is to suppress TSH to prevent recurrence of thyroid cancer, while avoiding overtreatment and hyperthyroidism. Regular monitoring of TSH, free T4, and thyroglobulin (Tg) levels is essential. In patients with differentiated thyroid cancer (PTC and FTC), radioactive iodine (RAI) therapy may be administered to ablate any remaining thyroid tissue and treat microscopic disease. A low-iodine diet (LID) is typically recommended for 1-2 weeks prior to RAI therapy to enhance iodine uptake by thyroid cells.</p>

 <h2 id="section6">Iodine and Thyroid Cancer</h2>
 <p>Iodine plays a crucial role in both the development and treatment of thyroid cancer. While iodine deficiency is a risk factor for thyroid nodules and some types of thyroid cancer, excessive iodine intake may also promote the growth of certain tumors. In the context of RAI therapy, a <span class="highlight">low-iodine diet (LID)</span> is essential to deplete the body's iodine stores and maximize the uptake of RAI by any remaining thyroid cancer cells. Patients on a LID should avoid iodized salt, seafood, dairy products, and certain medications and supplements that contain iodine (e.g., amiodarone, kelp).</p>

 <div class="case-study">
 <h3 class="case-study-title">Case Study: Sarah, 42-year-old Female</h3>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, a 42-year-old female, presented with a palpable nodule in her neck discovered during a routine physical exam.</p>
 <p><strong>Symptoms:</strong> Sarah reported no symptoms of hyperthyroidism or hypothyroidism. She had no family history of thyroid cancer.</p>
 <p><strong>Intervention:</strong> Thyroid ultrasound revealed a 1.5 cm hypoechoic nodule with irregular margins and microcalcifications in the right lobe. FNA biopsy was performed under ultrasound guidance. Cytology revealed Bethesda category V (Suspicious for Malignancy). Molecular testing was performed on the FNA sample and showed a BRAF V600E mutation, highly specific for papillary thyroid carcinoma.</p>
 <p><strong>Outcomes:</strong> Sarah underwent a total thyroidectomy with central neck dissection. Pathology confirmed papillary thyroid carcinoma, stage pT1aN1aM0. She received radioactive iodine therapy and is currently on thyroid hormone replacement therapy with regular monitoring of TSH and thyroglobulin levels. Sarah was also educated on the importance of a low-iodine diet prior to RAI therapy to maximize the effectiveness of the treatment. Sarah's G.L.A.N.D. framework was addressed with specific attention paid to Gut health and Detoxification, as well as optimizing hormone levels.</p>
 </div>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>

 <p><strong>Question 1:</strong> What ultrasound features are most suggestive of malignancy in a thyroid nodule?</p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Hypoechogenicity, irregular margins, microcalcifications, and a taller-than-wide shape are all ultrasound features that increase the suspicion for malignancy.</div>

 <p><strong>Question 2:</strong> Explain the purpose of a low-iodine diet prior to radioactive iodine therapy.</p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">A low-iodine diet is used to deplete the body's iodine stores, thereby enhancing the uptake of radioactive iodine by any remaining thyroid cancer cells during RAI therapy.</div>

 <p><strong>Question 3:</strong> How does the Bethesda System for Reporting Thyroid Cytopathology guide clinical management of thyroid nodules?</p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The Bethesda System categorizes FNA biopsy results into six diagnostic categories, each with an associated risk of malignancy and recommended management strategy, ranging from clinical follow-up to surgical excision.</div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Thyroid nodules are common, but most are benign. Ultrasound and FNA biopsy are essential for evaluation.</li>
 <li>The Bethesda System standardizes the reporting of thyroid cytology results and guides clinical decision-making.</li>
 <li>Papillary thyroid carcinoma is the most common type of thyroid cancer and has an excellent prognosis.</li>
 <li>Post-thyroidectomy management includes lifelong thyroid hormone replacement and regular monitoring for recurrence.</li>
 <li>A low-iodine diet is crucial for maximizing the effectiveness of radioactive iodine therapy.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ul>
 <li>Gharib, H., Papini, E., Garber, J. R., et al. (2013). "American Association of Clinical Endocrinologists, American Thyroid Association, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules." <em>Endocrine Practice</em>, 19(Suppl 2), 1-51.</li>
 <li>Cibas, E. S., & Ali, S. Z. (2017). "The 2017 Bethesda System for Reporting Thyroid Cytopathology." <em>Thyroid</em>, 27(11), 1341-1346.</li>
 <li>Nikiforov, Y. E., Carty, S. E., Chiosea, S. I., et al. (2011). "Impact of the molecular classification of thyroid tumors on the management of patients with thyroid nodules: a report of the Ad Hoc Committee of the American Thyroid Association on Molecular Testing in Thyroid Nodules." <em>Thyroid</em>, 21(7), 711-730.</li>
 <li>Haugen, B. R., Alexander, E. K., Bible, K. C., et al. (2016). "2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer." <em>Thyroid</em>, 26(1), 1-133.</li>
 <li>Cooper, D. S., Doherty, G. M., Haugen, B. R., et al. (2009). "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer." <em>Thyroid</em>, 19(11), 1167-1214.</li>
 <li>Durante, C., Costante, G., Lucisano, G., et al. (2006). "The natural history of papillary thyroid microcarcinoma: analysis of 100 cases of active surveillance." <em>Journal of Clinical Endocrinology & Metabolism</em>, 91(12), 4924-4928.</li>
 <li>Pacini, F., Schlumberger, M., Dralle, H., et al. (2006). "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium." <em>European Journal of Endocrinology</em>, 154(6), 787-803.</li>
 </ul>
 </div>
 </div>
 <script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
 </script>
</body>

</html>
